To date, two incretins, glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), have been identified
Gastroenterology 136 , 12251233 (2009)
Our weight loss program in Wading River, New York offers a comprehensive suite of progress tracking tools and resources designed to support your journey every step of the way
The UK medicines regulator, the MHRA, has updated the product information for healthcare professionals and patients regarding the "small risk of severe acute pancreatitis in patients taking GLP-1s." While rare, the sheer scale of GLP-1 use in the UK with one recent study suggesting 1.6 million adults had used them in the last 12 months, and 3.3 million were interested in trying them in the following year makes it important for clinicians and patients to be aware of the warning signs of pancreatitis, said the regulator
That means they dont just scroll through the posts of one or two loud voices in one space and research whos funding or backing them